Related Experiment Video
Updated: Mar 14, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Replicating ¡Cuídate!: 6-Month Impact Findings of a Randomized Controlled Trial
Meredith Kelsey1, Carolyn Layzer1, Jean Layzer1
1Meredith Kelsey, Carolyn Layzer, Cristofer Price, Randall Juras, Michelle Blocklin and Jacqueline Mendez are with Abt Associates, Inc., Cambridge, MA. Jean Layzer is with Belmont Research Associates, Belmont, MA.
Objectives:
To test whether ¡Cuídate!, a program culturally adapted for Hispanic youths, affects sexual risk behavior.
Methods:
We evaluated 3 replications of ¡Cuídate! in California, Arizona, and Massachusetts in a randomized controlled trial (registry no. NCT02540304) in which 2169 primarily Hispanic participants were randomly assigned to an intervention (n = 1326) or a control (n = 870) group. Youths were surveyed at baseline (September 2012-April 2014) and 6 months postbaseline (March 2013-October 2014). We estimated pooled and subgroup impacts using a regression framework with baseline covariates to increase statistical precision (1216 youths analyzed in the treatment group, 806 analyzed in the control group).
Results:
We found no impacts on the study's primary outcomes of recent sexual activity or recent unprotected sexual activity. However, ¡Cuídate! improved knowledge (10%-20% increase; P < .001), attitudes (effect size = .24; P < .001), and skills (effect size = .14; P = .002). Exploratory subgroup analyses suggest potentially problematic effects for some groups.
Conclusions:
Findings suggest that ¡Cuídate! was effective in improving youths' knowledge and attitudes. However, after 6 months, these changes did not translate to improvements in reported sexual risk behaviors.
Related Concept Videos
Clinical Trials: Overview
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioavailability Study Design: Healthy Subjects Versus Patients
Blinding
Clinical Trials
There are four phases in a clinical trial. A phase one...
Longitudinal Research